new tirzepatide drug FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly weight-loss drug appears

Nausea, diarrhea, and digestive discomfort occur somewhat more frequently with tirzepatide than with semaglutide

Jiayu Y, Botta A, Simtchouk S et al (2020) Egg white consumption increases GSH and lowers oxidative damage in 110-week-old geriatric mice hearts

Cardiovascular Safety Studies With DPP-4 Inhibitors The Clinical Guidance for Pharmaceutical IndustryDiabetes MellitusEvaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes established by the FDA in 2008 as a consequence of adverse safety signals of rosiglitazone has set up the requirement for novel diabetes medications to prove cardiovascular safety of these substances in comparison to standard therapy under glycaemic equipoise

Yes, Retadose is completely free

GLP-1 medications appear to break this pattern